Volume 78, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


In Martinique, a man bitten two days earlier by a pit viper () was hospitalized with impaired consciousness and tetraplegia. Investigations confirmed cerebral and myocardial infarctions. Resolving thrombocytopenia was associated with virtually normal blood prothrombin time/activated partial thromboplastin time but increasing hyperfibrinogenemia. Despite specific antivenom treatment, he developed fatal left ventricular failure six days after the bite. At autopsy, multiple cerebral, myocardial and mesenteric infarctions were found. Rupture of mitral chordae tendinae was the likely cause of death. Histopathologic examination showed multi-focal thrombotic microangiopathy with intimal-medial dissection by thrombi extending from foci of endothelial damage in small cerebral, myocardial, pulmonary, mesenteric, and interlobular renal arteries and arterioles. These findings were the causes of infarctions. There was intense angiogenesis in organizing cerebral infarcts. Immunohistochemical analysis showed platelet aggregates and endothelial cells within microthrombi. venoms contain vascular endothelial toxins, notably metalloproteinase hemorrhagins, but von Willebrand factor activators or vascular endothelial growth factor–type factors are more likely to have been implicated in this case.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Wüster W, Thorpe RS, Salomão MD, Thomas L, Puorto G, Theakston RD, Warrell DA, 2002. Origin and phylogenetic position of the Lesser Antillean species of Bothrops (Serpentes Viperidae): biogeographical and medical implications. Bull Nat Hist Mus Lond (Zool) 68 : 101–106. [Google Scholar]
  2. Thomas L, Tyburn B, Bucher B, Pecout F, Ketterlé J, Rieux D, Samdja D, Garnier D, Plumelle Y, and the Research Group on Snake Bites in Martinique, 1995. Prevention of thromboses in human patients with Bothrops lanceolatus envenoming in Martinique: failure of anticoagulants and efficacy of a monospecific antivenom. Am J Trop Med Hyg 52 : 419–426. [Google Scholar]
  3. Thomas L, Tyburn B, Ketterlé J, Biao T, Mehdaoui H, Moravie V, Rouvel C, Plumelle Y, Bucher B, Canonge D, Marie-Nelly CA, Lang J, and Other Members of the Research Group on Snake Bites in Martinique, 1998. Prognostic significance of clinical grading of patients envenomed by Bothrops lanceolatus in Martinique. Trans R Soc Trop Med Hyg 92 : 542–545. [Google Scholar]
  4. Numeric P, Moravie V, Didier M, Chatot-Henry D, Cirille S, Bucher B, Thomas L, 2002. Multiple cerebral infarctions following a snakebite by Bothrops caribbaeus. Am J Trop Med Hyg 67 : 287–288. [Google Scholar]
  5. Thomas L, Chausson N, Uzan J, Kaidomar S, Vignes R, Plumelle Y, Bucher B, Smadja D, 2006. Thrombotic stroke following snake bites by the “Fer-de-Lance” Bothrops lanceolatus in Martinique despite antivenom treatment: a report of three recent cases. Toxicon 48 : 23–28. [Google Scholar]
  6. Ameratunga B, 1972. Middle cerebral artery occlusion following Russell’s viper bite. J Trop Med Hyg 75 : 95–97. [Google Scholar]
  7. Murthy JK, Kishore LT, Naidu KS, 1997. Cerebral infarction after envenomation by viper. J Comput Assist Tomogr 21 : 35–37. [Google Scholar]
  8. Kornalik F, 1985. The influence of snake venom enzymes on blood coagulation. Pharmacol Ther 29 : 353–405. [Google Scholar]
  9. Aravanis C, Ioannidis P, Ktenas J, 1982. Acute myocardial infarction and cerebrovascular accident in a young girl after a viper bite. Br Heart J 47 : 500–503. [Google Scholar]
  10. Tony JC, Bhat R, 1995. Acute myocardial infarction following snakebite. Trop Doct 25 : 137. [Google Scholar]
  11. Blondheim DS, Plich M, Borman M, Khair G, Tzvig L, Ezri J, Marmor AT, 1996. Acute myocardial infarction complicating viper bite. Am J Cardiol 78 : 492–493. [Google Scholar]
  12. Bashir R, Jinkins J, 1985. Cerebral infarction in a young female following a snake bite. Stroke 16 : 328–330. [Google Scholar]
  13. Beer E, Musiani R, 1998. A case of intestinal infarction following Vipera aspis bite. Toxicon 36 : 729–733. [Google Scholar]
  14. Hung DZ, Wu ML, Deng JF, Yang DY, Lin-Shiau SY, 2002. Multiple thrombotic occlusions of vessels after Russell’s viper envenoming. Pharmacol Toxicol 91 : 106–110. [Google Scholar]
  15. Rosenthal R, Meier J, Koelz A, Müller C, Wegmann W, Vogelbach P, 2002. Intestinal ischemia after bushmaster (Lachesis muta) snakebite: a case report. Toxicon 40 : 217–220. [Google Scholar]
  16. Bush S, 2007. Fatal and Horrific Rattlesnake Bites. Venom Week, Tucson, AZ: University of Arizona. September 3–7, 2007.
  17. Warrell DA, 2004. Snakebites in Central and South America: epidemiology, clinical features, and clinical management. Bothrops lanceolatus. Campbell JA, Lamar WW, eds. The Venomous Reptiles of the Western Hemisphere. New York: Cornell University Press; 743–744.
  18. Nachman NL, Silverstein R, 1993. Hypercoagulable states. Ann Intern Med 119 : 819–827. [Google Scholar]
  19. Benvenuti LA, França FO, Barbaro KC, Nunes JR, Cardoso JL, 2003. Pulmonary haemorrhage causing rapid death after Bothrops jararacussu snakebite: a case report. Toxicon 42 : 331–334. [Google Scholar]
  20. Than-Than, Francis N, Tin-Nu-Swe, Myint-Lwin, Tun-Pe, Soe-Soe, Maung-Maung-Oo, Phillips RE, Warrell DA, 1989. Contribution of focal haemorrhage and microvascular fibrin deposition to fatal envenoming by Russell’s viper ( Vipera russelli siamensis) in Burma. Acta Trop 46 : 23–38. [Google Scholar]
  21. Moura-da-Silva AM, Butera D, Tanjomi I, 2007. Importance of snake venom metalloproteinases in cell biology: effects on platelets, inflammatory and endothelial cells. Curr Pharm Des 13 : 2893–2905. [Google Scholar]
  22. Serrano SM, Wang D, Shannon JD, Pinto AF, Polanowska-Grabowska RK, Fox JW, 2007. Interaction of the cysteine-rich domain of snake venom metalloproteinases with the A1 domain of von Willebrand factor promotes site-specific proteolysis of von Willebrand factor and inhibition of von Willebrand factor-mediated platelet aggregation. FEBS J 274 : 3611–3621. [Google Scholar]
  23. Stroka A, Donato JL, Bon C, Hyslop S, de Araújo AL, 2005. Purification and characterization of a hemorrhagic metalloproteinase from Bothrops lanceolatus (Fer-de-lance) snake venom. Toxicon 45 : 411–420. [Google Scholar]
  24. Yamazaki Y, Nakano Y, Imamura T, Morita T, 2007. Augmentation of vascular permeability of VEGF is enhanced by KDR-binding proteins. Biochem Biophys Res Commun 355 : 693–699. [Google Scholar]
  25. Ruggenenti P, Noris M, Remuzzi G, 2001. Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Intern 60 : 831–846. [Google Scholar]
  26. Grabowski EF, 2002. The Hemolytic-uremic syndrome-toxin, thrombin, and thrombosis. N Engl J Med 346 : 58–61. [Google Scholar]
  27. Chauhan AK, Motto DG, Lamb CB, Bergmeier W, Dockal M, Plaimauer B, Scheiflinger F, Ginsburg D, Wagner DD, 2006. Systemic antithrombotic effects of ADAMTS13. J Exp Med 203 : 767–776. [Google Scholar]
  28. Tsai HM, 2007. Thrombotic thrombocytopenic purpura: a thrombotic disorder caused by ADAMTS13 deficiency. Hematol Oncol Clin North Am 21 : 609–632. [Google Scholar]
  29. Kobayashi T, Wada H, Nishioka N, Yamamoto M, Matsumoto T, Tamaru T, Nomura S, Masuya M, Mori Y, Nakatani K, Nishikawa M, Katayam N, Nobori T, 2007. ADAMTS13 related markers and von Willebrand factor in plasma from patients with thrombotic microangiopathy (TMA). Thromb Res [Epub ahead of print]. [Google Scholar]
  30. Moake JL, 2002. Thrombotic microangiopathies. N Engl J Med 347 : 589–600. [Google Scholar]
  31. Perez L, Ramappa P, Guzman JA, 2007. Myocardial injury in thrombotic thrombocytopenic purpura: a frequent, perplexing complication. Int J Cardiol. [Epub ahead of print] [Google Scholar]
  32. Kamioka I, Nozu K, Fujita T, Kaito H, Tanaka R, Yoshiya K, Iijima K, Nakanishi K, Yoshikawa N, Matsuo M, 2007. Prognosis and pathological characteristics of five children with non-Shiga toxin-mediated hemolytic uremic syndrome. Pediatr Int 49 : 196–201. [Google Scholar]
  33. Kentouche K, Zintl F, Angerhaus D, Fuchs D, Hermann J, Schneppenheim R, Budde U, 2006. von Willebrand factor-cleaving protease (ADAMTS13) in the course of stem cell transplantation. Semin Thromb Hemost 32 : 98–104. [Google Scholar]
  34. Asherson RA, Cervera R, Piette JC, Font J, Lie JT, Burcoglu A, Lim K, Munoz-Rodriguez FJ, Levy RA, Boue F, Rossert J, Ingelmo M, 1998. Catastrophic antiphospholipid syndrome: clinical and laboratory features of 50 patients. Medicine 77 : 195–207. [Google Scholar]
  35. Tsirpanlis G, Moustakas G, Sakka E, Triantafyllis G, Sotsiou F, Liapis H, Ziroyannis P, 2005. Catastrophic antiphospholipid syndrome in a 14-year-old child. Pediatr Nephrol 20 : 519–521. [Google Scholar]
  36. Mizuno R, Fujimoto S, Fujimoto T, Nishino T, Shiiki H, Hashimoto T, Nakamura S, Dohi K, 2000. Catastrophic antiphospholipid antibody syndrome in systemic lupus erythematosus: an autopsy case report of a young woman. Intern Med 39 : 856–859. [Google Scholar]
  37. Starakis I, Mazokopakis E, Siagris D, Liossis S, Karatza C, Antonopoulos A, 2007. Catastrophic antiphospholipid syndrome presented with severe hypertension, adult respiratory distress syndrome and unilateral adrenal haemorrhagic infarction. Rheumatol Int 27 : 781–783. [Google Scholar]

Data & Media loading...

  • Received : 27 Nov 2007
  • Accepted : 18 Jan 2008

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error